High dose radioimmunotherapy in malignant lymphoma

Recent Results Cancer Res. 1996:141:177-82. doi: 10.1007/978-3-642-79952-5_12.

Authors

J F Eary¹, O W Press

Affiliation

¹ Division of Nuclear Medicine, University of Washington Medical Center, Seattle 98195, USA.

PMID: 8722427
DOI: 10.1007/978-3-642-79952-5_12

No abstract available

Publication types

Clinical Trial
Clinical Trial, Phase I
Clinical Trial, Phase II

MeSH terms

Antibodies, Monoclonal / therapeutic use
Antigens, CD20 / immunology
B-Lymphocytes / immunology
Dose-Response Relationship, Radiation
Humans
Immunoconjugates / therapeutic use*
Iodine Radioisotopes / therapeutic use*
Lymphoma / radiotherapy*
Radioimmunotherapy*
Radiotherapy Dosage
Remission Induction

Substances

Antibodies, Monoclonal
Antigens, CD20
Immunoconjugates
Iodine Radioisotopes